Mutual of America Capital Management’s PTC Therapeutics PTCT Stock Holding History

Mutual of America Capital Management’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$775K	Buy	9,500 +312	+3%	+$22.5K	0.01%	1044
2026 Q1	$626K	Buy	9,188 +12	+0.1%	+$850	0.01%	1024
2025 Q4	$697K	Buy	+9,176	New	+$667K	0.01%	1019
2016 Q1	–	Sell	-18,056	Closed	-$585K	–	1235
2015 Q4	$585K	Buy	18,056 +107	+0.6%	+$3.15K	0.01%	1089
2015 Q3	$479K	Hold	17,949	–	–	0.01%	1114
2015 Q2	$864K	Buy	17,949 +9,200	+105%	+$537K	0.02%	1054
2015 Q1	$532K	Buy	+8,749	New	+$534K	0.01%	1102

Other funds holding PTCT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Mutual of America Capital Management's PTCT Position: Q2 2026 in Review

Mutual of America Capital Management increased its PTC Therapeutics (PTCT) stake by 3.4% in Q2 2026, buying an estimated $22.5K and bringing the position to 9,500 shares worth $775K. The position accounts for 0.01% of the portfolio, ranked #1044.

Mutual of America Capital Management first reported a position in PTCT in Q1 2015 and has held it in 7 quarters since. The position peaked at $864K in Q2 2015. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

Mutual of America Capital Management held 9,500 shares of PTC Therapeutics worth $775K as of Q2 2026.
Mutual of America Capital Management bought 312 PTC Therapeutics shares in Q2 2026, an estimated $22.5K.
PTC Therapeutics made up 0.01% of Mutual of America Capital Management's portfolio in Q2 2026, its #1044 holding.
Mutual of America Capital Management first reported a position in PTC Therapeutics in Q1 2015 and has held it in 7 quarters since.
Mutual of America Capital Management's PTC Therapeutics position peaked at $864K in Q2 2015.
382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.